03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Retrovir Oral Solution* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | GSK |
Responsible Party | The Wellcome Foundation Ltd |
Origin | UK |
Manufacturer | The Wellcome Foundation Ltd |
Origin | UK |
ATC | J05AF01 |
Retrovir Oral Solution* :
Retrovir Oral Solution* :
Retrovir Oral Solution* :
Retrovir Oral Solution* :
Retrovir Oral Solution* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Retrovir Oral Solution* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Anaemia | Common |
Anorexia | Rare |
Anxiety | Rare |
Aplasia pure red cell (PRCA) | Rare |
Aplastic anemia | Very rare |
Asthenia | Uncommon |
Blood bilirubin increased | Common |
Bone marrow failure | Uncommon |
Cardiomyopathy | Rare |
Chest pain | Rare |
Chills | Rare |
Convulsion | Rare |
Cough | Rare |
Depression | Rare |
Diarrhoea (Diarrhea) | Common |
Dizziness | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Rare |
Dyspepsia | Rare |
Dyspnoea (dyspnea) | Uncommon |
Fever | Uncommon |
Flatulence | Uncommon |
Gynecomastia (Gynaecomastia) | Rare |
Headache | Very Common |
Hepatic enzyme increased | Common |
Hepatic steatosis | Rare |
Hepatomegaly | Rare |
Influenza-like symptoms | Rare |
Insomnia | Rare |
Lactic acidosis | Rare |
Leucopenia (Leukopenia) | Common |
Liver disorder | Rare |
Malaise | Common |
Myalgia | Common |
Myopathy | Uncommon |
Nail pigmentation | Rare |
Nausea | Very Common |
Neutropenia | Common |
Oral mucosal discolouration | Rare |
Pain | Uncommon |
Pancreatitis | Rare |
Pancytopenia | Uncommon |
Paraesthesia (paresthesia) | Rare |
Pigmentation skin | Rare |
Pollakiuria (Urinary frequency) | Rare |
Pruritus | Uncommon |
Skin rash | Uncommon |
Somnolence | Rare |
Sweating | Rare |
Thrombocytopenia (Thrombopenia) | Uncommon |
Urticaria | Rare |
Vomiting | Common |
Retrovir Oral Solution* :
NB : Products With Same Indication |
Different Units By MoH Code
Retrovir Oral Solution* MoH 699 :
Form | Oral solution |
Packaging | Bottle (Glass) |
Package Size | 200ml |
Strength | 50mg/5ml |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 135296/97 |
Submission date | 01/01/1997 |
Registration Year | 1997 |
Archived Date | 2014 |
Price Comparison
● Country: | Turkey | |
● Package Size: | 5x20ml | |
● Public Price: | 194.94 TRY | ( 522,439.20 LBP ) |
● Pack size unit used: | 100 | |
● Cost/Unit: | 1,9494 TRY | ( 2,680.00 LBP ) |
● Pricing Date: | 28/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Qatar | |
● Package Size: | 200ml | |
● Public Price: | 94 QAR | ( 2,308,452.00 LBP ) |
● Pack size unit used: | 200 | |
● Cost/Unit: | 0,47 QAR | ( 0.00 LBP ) |
● Pharmacy Price: | 77.3959923672 QAR | ( 1900690.7805537 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 200ml | |
● Public Price: | 68.75 SAR | ( 1,625,250.00 LBP ) |
● Pack size unit used: | 200 | |
● Cost/Unit: | 0,3438 SAR | ( 0.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 200ml | |
● Public Price: | 36.9 EUR | ( 3,574,724.40 LBP ) |
● Pack size unit used: | 200 | |
● Cost/Unit: | 0,1845 EUR | ( 0.00 LBP ) |
● Pharmacy Price: | 29.9 EUR | ( 2896592.4 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 200 ml |
● Exfactory Price: | 30.45 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File